Decrease in Incidence of Colorectal Cancer Among Individuals 50 Years or Older After Recommendations for Population-based Screening

Clinical Gastroenterology and Hepatology

Volumn 15, Issue 6, 2017, Pages 903-909.e6

  Murphy, Caitlin C ^a,b   Sandler, Robert S ^b,c   Sanoff, Hanna K ^d   Yang, Y Claire ^d   Lund, Jennifer L ^b   Baron, John A ^b,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b IL   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Colon Cancer; Early Detection; Endoscopy; Epidemiology; Tumor

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ASCENDING COLON; BLACK PERSON; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER REGISTRY; CANCER SCREENING; CANCER STAGING; CAUCASIAN; COLORECTAL CANCER; CONTROLLED STUDY; DESCENDING COLON; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; POPULATION RESEARCH; RACE DIFFERENCE; RECTUM; VERY ELDERLY; AGE; COLORECTAL TUMOR; EARLY CANCER DIAGNOSIS; INCIDENCE; MIDDLE AGED; UNITED STATES; UTILIZATION; YOUNG ADULT;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; HUMANS; INCIDENCE; MIDDLE AGED; UNITED STATES; YOUNG ADULT;

EID: 85009363562     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2016.08.037     Document Type: Article

References (67)

1. 1 Siegel, R., Desantis, C., Jemal, A., Colorectal cancer statistics, 2014. CA Cancer J Clin 64 (2014), 104–117.
2. 2 Surveillance, Epidemiology, and End Results (SEER) program (www.seer.cancer.gov) SEER*Stat Database: incidence - SEER 9 Regs Research Data, Nov 2015 Sub (1973–2013) - Linked To County Attributes - Total U.S., 1969–2014 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2016, based on the November 2015 submission.
3. 3 You, Y.N., Xing, Y., Feig, B.W., et al. Young-onset colorectal cancer: is it time to pay attention?. Arch Intern Med 172 (2012), 287–289.
4. 4 O'Connell, J.B., Maggard, M.A., Liu, J.H., et al. Rates of colon and rectal cancers are increasing in young adults. Am Surg 69 (2003), 866–872.
5. 5 Cress, R.D., Morris, C., Ellison, G.L., et al. Secular changes in colorectal cancer incidence by subsite, stage at diagnosis, and race/ethnicity, 1992–2001. Cancer 107 (2006), 1142–1152.
6. 6 Fairley, T.L., Cardinez, C.J., Martin, J., et al. Colorectal cancer in U.S. adults younger than 50 years of age, 1998–2001. Cancer 107 (2006), 1153–1161.
7. 7 Siegel, R.L., Jemal, A., Ward, E.M., Increase in incidence of colorectal cancer among young men and women in the United States. Cancer Epidemiol Biomarkers Prev 18 (2009), 1695–1698.
8. 8 Bailey, C.E., Hu, C.Y., You, Y.N., et al. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975–2010. JAMA Surg 150 (2015), 17–22.
9. 9 Meyer, J.E., Narang, T., Schnoll-Sussman, F.H., et al. Increasing incidence of rectal cancer in patients aged younger than 40 years: an analysis of the Surveillance, Epidemiology, and End Results database. Cancer 116 (2010), 4354–4359.
10. 10 Abdelsattar, Z.M., Wong, S.L., Regenbogen, S.E., et al. Colorectal cancer outcomes and treatment patterns in patients too young for average-risk screening. Cancer 122 (2016), 929–934.
11. 11 Sutton, E., Bellini, G., Lee, D., et al. Tu1812 An update on young-onset colorectal cancer, an NCDB analysis. Gastroenterology, 150, 2016, S1260.
12. 12 Schellerer, V.S., Hohenberger, W., Croner, R.S., Is it time to lower the recommended screening age for colorectal cancer?. J Am Coll Surg 214 (2012), 377–378 author reply 378–379.
13. 13 Savas, N., Dagli, U., Akbulut, S., et al. Colorectal cancer localization in young patients: should we expand the screening program?. Dig Dis Sci 52 (2007), 798–802.
14. 14 Davis, D.M., Marcet, J.E., Frattini, J.C., et al. Is it time to lower the recommended screening age for colorectal cancer?. J Am Coll Surg 213 (2011), 352–361.
15. 15 Agrawal, S., Bhupinderjit, A., Bhutani, M.S., et al. Colorectal cancer in African Americans. Am J Gastroenterol 100 (2005), 515–523 discussion 514.
16. 16 Kupfer, S.S., Carr, R.M., Carethers, J.M., Reducing colorectal cancer risk among African Americans. Gastroenterology 149 (2015), 1302–1304.
17. 17 Paquette, I.M., Ying, J., Shah, S.A., et al. African Americans should be screened at an earlier age for colorectal cancer. Gastrointest Endosc 82 (2015), 878–883.
18. 18 Lansdorp-Vogelaar, I., van Ballegooijen, M., Zauber, A.G., et al. Individualizing colonoscopy screening by sex and race. Gastrointest Endosc 70 (2009), 96–108 108.e1–e24.
19. 19 Klabunde, C.N., Cronin, K.A., Breen, N., et al. Trends in colorectal cancer test use among vulnerable populations in the United States. Cancer Epidemiol Biomarkers Prev 20 (2011), 1611–1621.
20. 20 Shapiro, J.A., Seeff, L.C., Thompson, T.D., et al. Colorectal cancer test use from the 2005 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev 17 (2008), 1623–1630.
21. 21 Seeff, L.C., Nadel, M.R., Klabunde, C.N., et al. Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer 100 (2004), 2093–2103.
22. 22 Shapiro, J.A., Klabunde, C.N., Thompson, T.D., et al. Patterns of colorectal cancer test use, including CT colonography, in the 2010 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev 21 (2012), 895–904.
23. 23 Edwards, B.K., Ward, E., Kohler, B.A., et al. Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 116 (2010), 544–573.
24. 24 Vogelaar, I., van Ballegooijen, M., Schrag, D., et al. How much can current interventions reduce colorectal cancer mortality in the U.S.? mortality projections for scenarios of risk-factor modification, screening, and treatment. Cancer 107 (2006), 1624–1633.
25. 25 Zauber, A.G., Winawer, S.J., O'Brien, M.J., et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 366 (2012), 687–696.
26. 26 Cronin, K.A., Krebs-Smith, S.M., Feuer, E.J., et al. Evaluating the impact of population changes in diet, physical activity, and weight status on population risk for colon cancer (United States). Cancer Causes Control 12 (2001), 305–316.
27. 27 Welch, H.G., Robertson, D.J., Colorectal cancer on the decline: why screening can't explain it all. N Engl J Med 374 (2016), 1605–1607.
28. 28 Singh, H., Nugent, Z., Demers, A.A., et al. The reduction in colorectal cancer mortality after colonoscopy varies by site of the cancer. Gastroenterology 139 (2010), 1128–1137.
29. 29 Rex, D.K., Johnson, D.A., Anderson, J.C., et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol 104 (2009), 739–750.
30. 30 Brenner, H., Hoffmeister, M., Arndt, V., et al. Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study. J Natl Cancer Inst 102 (2010), 89–95.
31. 31 Baxter, N.N., Warren, J.L., Barrett, M.J., et al. Association between colonoscopy and colorectal cancer mortality in a US cohort according to site of cancer and colonoscopist specialty. J Clin Oncol 30 (2012), 2664–2669.
32. 32 Lansdorp-Vogelaar, I., Kuntz, K.M., Knudsen, A.B., et al. Contribution of screening and survival differences to racial disparities in colorectal cancer rates. Cancer Epidemiol Biomarkers Prev 21 (2012), 728–736.
33. 33 Doubeni, C.A., Field, T.S., Buist, D.S., et al. Racial differences in tumor stage and survival for colorectal cancer in an insured population. Cancer 109 (2007), 612–620.
34. 34 Laiyemo, A.O., Doubeni, C., Pinsky, P.F., et al. Race and colorectal cancer disparities: health-care utilization vs different cancer susceptibilities. J Natl Cancer Inst 102 (2010), 538–546.
35. 35 Doubeni, C.A., Major, J.M., Laiyemo, A.O., et al. Contribution of behavioral risk factors and obesity to socioeconomic differences in colorectal cancer incidence. J Natl Cancer Inst 104 (2012), 1353–1362.
36. 36 Robbins, A.S., Siegel, R.L., Jemal, A., Racial disparities in stage-specific colorectal cancer mortality rates from 1985 to 2008. J Clin Oncol 30 (2012), 401–405.
37. 37 Siegel, R.L., Jemal, A., Thun, M.J., et al. Trends in the incidence of colorectal cancer in relation to county-level poverty among blacks and whites. J Natl Med Assoc 100 (2008), 1441–1444.
38. 38 Meissner, H.I., Breen, N., Klabunde, C.N., et al. Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev 15 (2006), 389–394.
39. 39 Sabatino, S.A., White, M.C., Thompson, T.D., et al. Cancer screening test use: United States, 2013. MMWR Morb Mortal Wkly Rep 64 (2015), 464–468.
40. 40 Mandel, J.S., Church, T.R., Ederer, F., et al. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 91 (1999), 434–437.
41. 41 Hardcastle, J.D., Armitage, N.C., Chamberlain, J., et al. Fecal occult blood screening for colorectal cancer in the general population: results of a controlled trial. Cancer 58 (1986), 397–403.
42. 42 Hardcastle, J.D., Thomas, W.M., Chamberlain, J., et al. Randomised, controlled trial of faecal occult blood screening for colorectal cancer: results for first 107,349 subjects. Lancet 1 (1989), 1160–1164.
43. 43 Hardcastle, J.D., Chamberlain, J.O., Robinson, M.H., et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348 (1996), 1472–1477.
44. 44 Fenton, J.J., Elmore, J.G., Buist, D.S., et al. Longitudinal adherence with fecal occult blood test screening in community practice. Ann Fam Med 8 (2010), 397–401.
45. 45 Gellad, Z.F., Stechuchak, K.M., Fisher, D.A., et al. Longitudinal adherence to fecal occult blood testing impacts colorectal cancer screening quality. Am J Gastroenterol 106 (2011), 1125–1134.
46. 46 Liss, D.T., Petit-Homme, A., Feinglass, J., et al. Adherence to repeat fecal occult blood testing in an urban community health center network. J Community Health 38 (2013), 829–833.
47. 47 Myers, R.E., Balshem, A.M., Wolf, T.A., et al. Adherence to continuous screening for colorectal neoplasia. Med Care 31 (1993), 508–519.
48. 48 Rex, D.K., Khan, A.M., Shah, P., et al. Screening colonoscopy in asymptomatic average-risk African Americans. Gastrointest Endosc 51 (2000), 524–527.
49. 49 Thomas, C.R. Jr., Jarosz, R., Evans, N., Racial differences in the anatomical distribution of colon cancer. Arch Surg 127 (1992), 1241–1245.
50. 50 Theuer, C.P., Taylor, T.H., Brewster, W.R., et al. The topography of colorectal cancer varies by race/ethnicity and affects the utility of flexible sigmoidoscopy. Am Surg, 67, 2001, 1157.
51. 51 Chu, K.C., Tarone, R.E., Chow, W.H., et al. Colorectal cancer trends by race and anatomic subsites, 1975 to 1991. Arch Fam Med 4 (1995), 849–856.
52. 52 Cordice, J.W. Jr., Johnson, H. Jr., Anatomic distribution of colonic cancers in middle-class black Americans. J Natl Med Assoc 83 (1991), 730–732.
53. 53 Naylor, K., Ward, J., Polite, B.N., Interventions to improve care related to colorectal cancer among racial and ethnic minorities: a systematic review. J Gen Intern Med 27 (2012), 1033–1046.
54. 54 Knudsen, A.B., Zauber, A.G., Rutter, C.M., et al. Estimation of benefits, burden, and harms of colorectal cancer screening strategies: modeling study for the U.S. Preventive Services Task Force. JAMA 36 (2016), 604–614.
55. 55 Jamal, A., Homa, D.M., O'Connor, E., et al. Current cigarette smoking among adults: United States, 2005–2014. MMWR Morb Mortal Wkly Rep 64 (2015), 1233–1240.
56. 56 Daniel, C.R., Cross, A.J., Koebnick, C., et al. Trends in meat consumption in the USA. Public Health Nutr 14 (2011), 575–583.
57. 57 Larsson, S.C., Wolk, A., Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr 86 (2007), 556–565.
58. 58 Flegal, K.M., Carroll, M.D., Ogden, C.L., et al. Prevalence and trends in obesity among US adults, 1999–2008. JAMA 303 (2010), 235–241.
59. 59 Winawer, S.J., Miller, D.G., Schottenfeld, D., et al. Feasibility of fecal occult-blood testing for detection of colorectal neoplasia: debits and credits. Cancer 40 (1977), 2616–2619.
60. 60 Hardcastle, J.D., Farrands, P.A., Balfour, T.W., et al. Controlled trial of faecal occult blood testing in the detection of colorectal cancer. Lancet 2 (1983), 1–4.
61. 61 National Cancer Institute, Working guidelines for early cancer detection: rationale and supporting evidence to decrease mortality. 1987, National Cancer Institute, Bethesda, MD.
62. 62 Cancer of the colon and rectum: summary of a public attitude survey. CA Cancer J Clin 33 (1983), 359–365.
63. 63 Howe, H.L., Wu, X., Ries, L.A., et al. Annual report to the nation on the status of cancer, 1975–2003, featuring cancer among US Hispanic/Latino populations. Cancer 107 (2006), 1711–1742.
64. 64 American Cancer Society, Cancer facts & figures for Hispanics. 2009, American Cancer Society, Atlanta, GA.
65. 65 Paskett, E.D., Khuri, F.R., Can we achieve an 80% screening rate for colorectal cancer by 2018 in the United States?. Cancer 121 (2015), 2127–2128.
66. 66 Fedewa, S.A., Ma, J., Sauer, A.G., et al. How many individuals will need to be screened to increase colorectal cancer screening prevalence to 80% by 2018?. Cancer 121 (2015), 4258–4265.
67. 67 Meester, R.G., Doubeni, C.A., Zauber, A.G., et al. Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018. Cancer 121 (2015), 2281–2285.